| van Lent, Horst-Dieter (Omnibal 200906 Head Purchasing) |
Business Manager |
Omnilab (DE) (Group) |
Germany |
| Van Min, Max (Cergentis 202004 Founding Director) |
Managing Director |
Solvias (Group) |
Netherlands |
| Van Naarden, Jacob (Loxo Oncology 201711 CBO) |
Chief Business Officer (CBO) |
Eli Lilly (Group) |
United States (USA) |
| van Pelt, Eva (Eppendorf 201912– Co-CEO joined 201710 before Leica Microsystems + Hitachi + Siemens) |
Chief Executive Officer (CEO) |
Eppendorf (Group) |
Germany |
| van Renterghem, Guillaume (LifeSci 202106 Managing Director at LifeSci Advisors in Zurich) |
Public Relations Manager / Investor Relations Manager |
LifeSci (Group) |
United States (USA) |
| Van Rie, Jeroen (Bayer 201706 Crop Efficiency Trait Research expert) |
n. a. |
Bayer (Group) |
Germany |
| van Tilburg, Maurice (Euronext 201511 CEO of Euronext Amsterdam) |
Chief Executive Officer (CEO) |
Euronext (Group) |
Netherlands |
| van Tulder, Arnoud (Cryo-Save 201105 CEO) |
Chief Executive Officer (CEO) |
Esperite (Group) |
Netherlands |
| van Tunen, Arjen (Keygene 200601 CEO) |
Chief Executive Officer (CEO) |
KeyGene N.V. |
Netherlands |
| Van Vlasselaer, Peter (Avidia 200609 CEO) |
Chief Executive Officer (CEO) |
Avigen Inc. (Nasdaq: AVGN) |
United States (USA) |
| van Wieringen, Bas (PeelPioneeres 202010) |
n. a. |
PeelPioneers B.V. |
Netherlands |
| van Winsen, Joris (Labfolder 2015– Managing Director CFO) |
Managing Director |
Labforward (Group) |
Germany |
| van Zyl, Charl (UCB 202101 EVP Head Neurology Solutions + Intl Markets formerly Jado Technologies + Novartis + Lilly) |
President/Director/Head Business Group/Unit/Division |
UCB (Group) |
Belgium |
| Vanacker, Peter (Neste 202012 CEO) |
Chief Executive Officer (CEO) |
Neste Oyj |
Finland |
| Vandenhirtz, Dirk (LemnaTec 201104 Managing Director) |
Managing Director |
Nynomic (Group) |
Germany |
| Vanderhaegen, Frederic (Tecan 201202 Head Life Sciences Business) |
President/Director/Head Business Group/Unit/Division |
Tecan (Group) |
Switzerland |
| Vangeel, Frankie (VWR 201602 Managing Director at VWR International GmbH) |
Managing Director |
Avantor (Group) |
Germany |
| Vanhoyland, Geert (Bruker 201606 Global Product Manager Materials Research at Bruker AXS) |
Product Manager (personnel) |
Bruker (Group) |
Germany |
| Vann, Christopher (Autolus 201707– COO before Roche) |
Chief Operating Officer (COO) |
Autolus Therapeutics plc (Nasdaq: AUTL) |
United Kingdom (GB) |
| VanOort, Douglas (NeoGenomics 201703 CEO) |
n. a. |
NeoGenomics (Group) |
United States (USA) |
| Varma, Suneet (Pfizer 201712 Global President of Pfizer APAC, Greater China + Global Brands) |
President/Director/Head Business Group/Unit/Division |
Pfizer (Group) |
United States (USA) |
| Varney, Michael D. (Roche 201501–202007 promoted Head of gRED before Genentech RETIRED 7/20) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
United States (USA) |
| Vasella, Daniel (Novartis CEO 199612–201001 after 1/10 continues as Chairman) |
Board member, non-executive |
Numab (Group) |
Switzerland |
| Vat-Ho, Vatnak (Ryvu Therapeutics 202104– US-based CBO before Affimed Inc + Pfizer) |
Chief Business Officer (CBO) |
Ryvu Therapeutics S.A. (WSE: RVU) |
Poland |
| Vater, Wulf (Bayer 199710) |
n. a. |
Bayer (Group) |
Germany |
| Vaussy, Hugues (Eurofins 201707 Finance Director) |
Chief Financial Officer (CFO) |
Eurofins (Group) |
Luxembourg |
| Vazirani, Suresh (Erba Diagnostics Mannheim 201509 Managing Director) |
Managing Director |
Erba Diagnostics Mannheim (Group) |
Germany |
| Végh, Mátyás (Creoptix 201210–201912 Managing Partner before Genetics Company LEFT 1/20) |
Managing Partner |
Spectris (Group) |
Switzerland |
| Veidman, Avi (Nucleai MD 202007 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Nucleai MD (IL) |
Israel |
| Veinbergs, Isaac (Libra Therapeutics 202009– CEO) |
Chief Executive Officer (CEO) |
Libra Therapeutics Inc. |
United States (USA) |
| Veitch, David (Basilea 201804– CEO before CCO since 201408 before Savient + BMS) |
Chief Executive Officer (CEO) |
Basilea (Group) |
Switzerland |
| Veitschegger, Andrea (ÖGMBT 201105 Managing Director) |
Managing Director |
Österreichische Gesellschaft für Molekulare Biowissenschaften und Biotechnologie (ÖGMBT) |
Austria |
| Velasco, Martin (AC Immune 201401 Board Chairman) |
Board member, non-executive |
AC Immune S.A. (Nasdaq: ACIU) |
Switzerland |
| Velden, Torsten (Bayer 201208 Bayer CropScience Country Head for Vietnam) |
Regional manager |
Bayer (Group) |
Germany |
| Veldman, Robert (Bipharma 201204 CEO) |
Chief Executive Officer (CEO) |
Bipharma B.V. |
Netherlands |
| Velling, Johannes (NRW (govt) 202106 Deputy Head Dept Startups + Digital Impulse at MWIDE before Germany (govt)) |
Administrative Officer (personnel) |
Nordrhein-Westfalen (govt region) |
Germany |
| Velten, Jürgen |
n. a. |
Baden-Württemberg (govt region) |
Germany |
| Venkayya, Rajeev (Aerium Therapeutics 202203– CEO before Takeda 201510 President of Vaccine Business Unit) |
Chief Executive Officer (CEO) |
Aerium Therapeutics Inc. |
United States (USA) |
| Venter, J. Craig |
n. a. |
VENTER Group [Craig Venter / Claire Fraser] (Group) |
United States (USA) |
| Ventur, Yvonne (Orexo 201207 Kibion Country Manager Germany) |
Regional manager |
Mayoly Spindler (Group) |
Germany |
| Venturi, Miro (Novigenix 202211 Board Director) |
Board member (all kinds of boards: supervisory, advisory, management etc.) |
Novigenix S.A. |
Switzerland |
| Veraart, Manon (Quercis Pharma 202104– CBO before Compass Pathways + Boston Consulting + Goldman Sachs) |
Chief Executive Officer (CEO) |
Quercis Pharma (Group) |
Switzerland |
| Veraitch, Farlan (Ori Biotech 202005 CSO + Co-Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Ori Biotech (Oribiotech) (Group) |
United Kingdom (GB) |
| Verbraeken, Paul (Evolva 201105 Investor Relations Manager) |
Public Relations Manager / Investor Relations Manager |
Evolva (Group) |
Switzerland |
| Verghese, Jacob (Trophic Communications 201811) |
Public Relations Manager / Investor Relations Manager |
Trophic Communications GmbH |
Germany |
| Verhaeghe, Peter (Benaruca 200910) |
Investment Manager |
Benaruca (LU) (family offfice of Rudi Pauwels) |
Luxembourg |
| Verhaert, Raymond (ProteoNic 201105 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
ProteoNic Biotechnology B.V. |
Netherlands |
| Verhey, Janko F. (MVIP ImagingProducts 200912 Managing Director + Co-Founder) |
Managing Director |
MVIP (Group) |
Germany |
| Verhey, Martina (MVIP ImagingProducts 200912 Managing Director + Co-Founder) |
Managing Director |
MVIP (Group) |
Germany |
| Verheyen, Frank (Techniker Krankenkasse 200901– Director of WINEG) |
President/Director/Head Business Group/Unit/Division |
Techniker Krankenkasse (Group) |
Germany |
| Verhoef, Clarence (Varex Imaging 201701– CFO) |
Chief Financial Officer (CFO) |
Varex Imaging (Group) |
United States (USA) |
| Verhoeven, Wouter (BioGeneration Ventures 202109– Venture Partner before NBE-Therapeutics + mAbxience) |
Partner (venture partner) |
BioGeneration Ventures B.V. (BGV) |
Netherlands |
| Verjee, Rehan (Precede Biosciences 202310 CEO + Co-Founder before EMD Serono) |
Chief Executive Officer (CEO) |
Precede Biosciences (US) |
United States (USA) |
| Verkamman, Annemiek (HollandBIO 201912 Managing Director) |
Managing Director |
HollandBIO |
Netherlands |
| Verland, Sten (Sunstone Capital 200705– Partner Life Science Ventures) |
Partner (venture partner) |
Sunstone Life Science (Group) |
Denmark |
| Verlenden, Darren (Merck (DE) 2022 Head of Proccess Solutions at Life Science Business Sector) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
Germany |
| Vermeylen, Krisja (Novo Group 201704 SPV Corp People + Organisation joined before 1997 before Pharmacia) |
President/Director/Head Business Group/Unit/Division |
Novo Group (Group) |
Denmark |
| Veromaa, Timo (BioTie 1998– VP RnD promoted CEO 5/05 before Schering Oy before Collagen Corp) |
Chief Executive Officer (CEO) |
Acorda Therapeutics (Group) |
Finland |
| Verrelst, Herman (Biocartis 202304– Board Chair before CEO before Agilent + Cartagenia + Medicim + Data4s) |
Board member, non-executive |
Biocartis (Group) |
Belgium |
| Vertes, Akos (George Washington Univ 2000– Prof before Associate Prof since 1991) |
Professor |
George Washington University |
United States (USA) |
| Ververken, Cedric (Confo Therapeutics 201610– CEO before Ablynx) |
Chief Executive Officer (CEO) |
Confo Therapeutics N.V. |
Belgium |
| Verwiel, Frank (ObsEva 2016– Board Director before CEO of Aptalis Pharma) |
n. a. |
ObsEva (Group) |
Switzerland |
| Verzetnitsch, Ulrike (Apceth 201612 CTO at Apceth Biopharma GmbH) |
Chief Technology/Technical Officer (CTO) |
Resonac (Group) |
Germany |
| Vessey, Rupert (Celgene 201701 EVP + President RnD before Merck & Co 200906 VP Merck Research Laboratories) |
President/Director/Head Business Group/Unit/Division |
Bristol Myers Squibb (BMS) (Group) |
United States (USA) |
| Vetter, Dirk (Perora GmbH 201306– Managing Director + Co-founder) |
Managing Director |
Perora GmbH |
Germany |
| Vetter, Nicholas (UV-Cap 202011) |
n. a. |
UV-Cap (Vetter family office) (Group) |
Germany |
| Vetter, Udo J. (UV-Cap 201702 Founder + Managing Director) |
Managing Director |
|
|
| Veugelers, Mark (VIB 201408 Tech Watch team) |
IP Manager |
VIB (Flanders Interuniversity Institute for Biotechnology / Vlaams Instituut voor Biotechnologie) |
Belgium |
| Vianna, Eduardo (NovaGo Therapeutics 202009– Chief Development Officer before CEO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
NovaGo Therapeutics AG |
Switzerland |
| Vicari, Alain (Calypso Biotech 201703 CEO) |
Chief Executive Officer (CEO) |
Calypso Biotech (Group) |
Switzerland |
| Viehbacher, Christopher A. (Chris) (Biogen 202307 CEO before Gurnet Point Capital + Sanofi + GSK) |
Managing Partner |
BERTARELLI Group (family of Ernesto Bertarelli) |
United Kingdom (GB) |
| Vieira, Samantha (Anjarium Biosciences 202207– COO before Biogen + Nightstar Therapeutics) |
Chief Operating Officer (COO) |
Anjarium Biosciences AG |
Switzerland |
| Vielsack, Claus (Stratec 201402– Executive Management Board Member for Product Development joined 1998) |
Board member, executive |
Stratec (Group) |
Germany |
| Viëtor, Henk (Oncodrone 201508 CEO before Skyline Diagnostics CEO) |
Chief Executive Officer (CEO) |
SkylineDx B.V. |
Netherlands |
| Vigneault, Francois (AbVitro 201410 CSO + Co-founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Bristol Myers Squibb (BMS) (Group) |
United States (USA) |
| Vignon, Guillaume (BeiGene 201810 SVP Business Development at BeiGene Switzerland GmbH) |
Business Development Manager / Strategy Manager |
BeiGene (Group) |
Switzerland |
| Vignot, Julien (Vifor Pharma 202111 Head of Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Vifor Pharma (Group) |
Switzerland |
| Vile, Hollie (Optimum Strategic Communicatons 201710 before Hume Brophy + M:Communications) |
Public Relations Manager / Investor Relations Manager |
Optimum Strategic Communications |
United Kingdom (GB) |
| Villain-Guillot, Philippe (Nosopharm 201703 President) |
Chief Executive Officer (CEO) |
Nosopharm S.A.S. |
France |
| Villinger, Thomas R. (Tom) (ZFHN Zukunftsfonds Heilbronn 201910 CEO) |
Chief Executive Officer (CEO) |
Zukunftsfonds Heilbronn (Group) |
Germany |
| Vincent, Kathy (Greig Communications 202301) |
Public Relations Manager / Investor Relations Manager |
Greig Communications Inc. |
United States (USA) |
| Vink, Patrick (Forbion 202007c– Operating Partner former COO of Cubist before Mylan + Sandoz) |
Partner (venture partner) |
Forbion (Group) |
Netherlands |
| Viragh, Eszter (BMS 202203 Head of Corporate Affairs at BMS Germany) |
Public Relations Manager / Investor Relations Manager |
Bristol Myers Squibb (BMS) (Group) |
Germany |
| Virani, Shafique (Recursion 202009 Chief Corp Development Officer formerly Roche Global Head Neuroscience Partnering) |
Business Development Manager / Strategy Manager |
Recursion Pharmaceuticals (Group) |
United States (USA) |
| Virchow, Sebastian |
n. a. |
Deutsche Bank (Group) |
Germany |
| Viribay, Miguel-Antonio (Sygnis 201504– VP Sales + Marketing before Thermo Fisher + Agilent + Life Technologies) |
Sales Manager / Marketing Manager |
2invest (Group) |
Germany |
| Virji, Sukaina (Suki) (Consilium 201706– joins London CSC office before 16y at Scrip/Informa) |
Public Relations Manager / Investor Relations Manager |
ICR (Group) |
United Kingdom (GB) |
| Viswanadhan, Krishnan (Be Biopharma 202208– COO + President before BMS + Celgene + Advyzom + Roche) |
Chief Operating Officer (COO) |
Be Biopharma Inc. |
United States (USA) |
| Vita, Giuseppe (Schering) |
n. a. |
Bayer (Group) |
Germany |
| Vitt, Daniel (Immunic 201701– CEO before 4SC 1997–201612 CSO + Co-Founder before Univ Würzburg) |
Chief Executive Officer (CEO) |
Immunic (Group) |
Germany |
| Vlachou, Angelika (High-Tech Gründerfonds 202110 VC Professional formerly bmp 201702 Investment Manager bmp) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Vlasak, Reinhard (Angewandte Biotechnologie GmbH 200810 CEO) |
Chief Executive Officer (CEO) |
Angewandte Biotechnologie GmbH (Applied BioTech – ABT) |
Austria |
| Vodopivec, Alexander (ViruSure 201211 Managing Director, Finance + Administration) |
Managing Director |
ViruSure GmbH |
Austria |
| Voegeli, Rainer (BioVisioN 200412 CBO) |
Chief Business Officer (CBO) |
Digilab (Group) |
Germany |
| Vogel, Bernard (Endeavour Vision 201409 Managing Partner + Co-founder) |
Managing Partner (investment firm) |
Endeavour Vision (Group) |
Switzerland |
| Vogel, Florian (MYR Pharmaceuticals 202006 CCO) |
Chief Commercial Officer (CCO) |
Gilead Sciences (Group) |
Germany |
| Vogel, Hanspeter (Bruker 201009 Director RI Research Instruments GmbH) |
n. a. |
Bruker (Group) |
Germany |
| Vogelmeier, Claus (Univ Gießen 201503 Professor of Internal + Respiratory Medicine) |
Professor |
University of Gießen (Justus Liebig University) |
Germany |
| Vogelstein, Bert (Johns Hopkins Univ 201704 Professor) |
Professor |
Johns Hopkins University |
United States (USA) |
| Vogeser, Gudrun (PIKA Weihenstephan GmbH 201308 Managing Director + Co-founder) |
Managing Director |
PIKA Weihenstephan GmbH |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 79 80 81 ... 86 87 88 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
